Article Versions Notes

Liu T, Gao H, Zhang Y, Wang S, Lu M, Dai X, Liu Y, Shi H, Xu T, Yin J, et al. Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442. Pharmaceuticals. 2023; 16(6):819. https://doi.org/10.3390/ph16060819

Liu, Tianyuan, Huimin Gao, Yueyi Zhang, Shan Wang, Meixi Lu, Xuan Dai, Yage Liu, Hanfen Shi, Tianshu Xu, Jiyuan Yin, and et al. 2023. "Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442" Pharmaceuticals 16, no. 6: 819. https://doi.org/10.3390/ph16060819

Liu, T., Gao, H., Zhang, Y., Wang, S., Lu, M., Dai, X., Liu, Y., Shi, H., Xu, T., Yin, J., Gao, S., Wang, L., & Zhang, D. (2023). Correction: Liu et al. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals 2022, 15, 1442. Pharmaceuticals, 16(6), 819. https://doi.org/10.3390/ph16060819